Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Surface Metals to Present at Fastmarkets Global Lithium, Battery & Critical Materials Conference in Las Vegas, Nevada
Nine Mile Metals Announces Completion of DDH WD-26-02,Intersecting 234.15 Meters of Visual Mineralization and Discovers a New Copper Rich VMS Horizon at the Wedge Mine
Freegold intersects 336.8 m grading 1.32 g/t Au starting from 26.5 m in Infill Drilling at Golden Summit
